SCHEMBL7314871

SCHEMBL7314871

N=C(NC(=O)c1ccc2ccccc2c1)c1ccc(N2CC(CN3CCN(CCC(=O)O)CC3)OC2=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.44
SIGMAR1 Q99720 3/20 0.42
DRD3 P35462 2/20 0.42
SLC6A4 P31645 2/20 0.40
SLC6A2 P23975 1/20 0.40
POLB P06746 1/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
DRD2 P14416 1/20 0.40
ADRA1A P35348 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
F10 P00742 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7304103 0.92 SIGMAR1 (0.44) SIGMAR1ITGB3ITGA2BF10
SCHEMBL6601180 0.91 ITGB3 (0.45) HTR1ASIGMAR1SLC6A4SLC6A2POLB
SCHEMBL6604885 0.89 ITGB3 (0.41) HTR1ASIGMAR1DRD3SLC6A2POLB
SCHEMBL6605691 0.89 ITGB3 (0.51) HTR1ASIGMAR1DRD3SLC6A4SLC6A2
SCHEMBL6603919 0.89 ITGB3 (0.42) HTR1ASIGMAR1SLC6A4SLC6A2POLB
SCHEMBL6602885 0.89 ITGB3 (0.42) HTR1ASIGMAR1DRD3SLC6A4SLC6A2
SCHEMBL7314580 0.88 ALDH1A1 (0.47) SIGMAR1DRD3ITGB3ITGA2BF10
SCHEMBL6601430 0.87 ITGB3 (0.43) HTR1ASIGMAR1DRD3SLC6A4SLC6A2
SCHEMBL7314863 0.86 SIGMAR1 (0.42) HTR1ASIGMAR1ITGB3ITGA2BF10
SCHEMBL6605806 0.86 ITGB3 (0.52) HTR1ASIGMAR1ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455529-B1 OXAZOLIDIN-2-ONE DERIVATIVES; ANTICOAGULANTS; ANTIMETASTASIS, ANTICARCINOGENIC, ANTIISCHEMIC, AND ANTIINFLAMMATORY AGENTS; OSTEOPOROSIS, ARTERIOSCLEROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-09-24 US disclosed
EP-0741133-A2 Adhesion receptor antagonists MERCK PATENT GmbH (DE) 1996-11-06 EP disclosed